Environmental

BHC’s environmental positioning is broadly in line with large healthcare peers, as its asset-light pharmaceutical model typically carries lower direct emissions than manufacturing-heavy industrial peers.

R&D intensity at 5.8% of revenue supports a more innovation-led footprint, but peer-relative environmental advantage remains limited because product and supply-chain impacts still dominate.

The company’s environmental profile is constrained by healthcare-sector exposure to packaging, waste, and supplier standards, which are material but generally comparable to peers.

No provided evidence indicates a structural environmental leadership gap or advantage versus peers, leaving the score anchored in a middle tier.

Social

BHC’s social positioning is supported by the essential nature of its healthcare products, which can strengthen stakeholder relevance versus non-healthcare peers.

The company’s high gross margin profile does not itself indicate social strength, but it can support continuity in patient access and service obligations relative to weaker peers.

Stock-based compensation at 1.4% of revenue suggests moderate dilution pressure, yet this is not clearly worse than peer norms in capital-intensive healthcare.

Absent disclosed recent controversy data, the social score reflects a mixed peer-relative profile with meaningful obligations but no clear structural advantage.

Governance

BHC’s leverage remains elevated, with net debt to EBITDA at 9.3x, which increases governance sensitivity around capital allocation and creditor oversight versus peers.

The negative debt-to-equity ratio indicates a balance-sheet structure that can complicate comparability and heighten scrutiny of financial controls and covenant management.

R&D spending at 5.8% of revenue signals ongoing investment discipline, but it does not offset the governance risk implied by high leverage relative to better-capitalized peers.

Without additional filing evidence on board independence, audit quality, or controversy history, governance remains below stronger healthcare peers but not severely impaired.

Overall Score

BHC’s overall ESG positioning is mixed and peer-comparable in environmental and social factors, but elevated leverage materially weakens governance relative to stronger healthcare peers.

Score Driver: High Leverage And Balance-Sheet Complexity